Optical Coherence Tomography assessment of the implantation of Everolimus-Eluting Bioresorbable Scaffolds against angiographic assessment: the clinical outcomes
dc.contributor.author | Hamshere, S | en_US |
dc.contributor.author | Byrne, A | en_US |
dc.contributor.author | Weerackody, R | en_US |
dc.contributor.author | Wragg, A | en_US |
dc.contributor.author | Knight, C | en_US |
dc.contributor.author | Mathur, A | en_US |
dc.contributor.author | Jones, D | en_US |
dc.date.accessioned | 2020-07-03T12:40:02Z | |
dc.date.issued | 2016-11-01 | en_US |
dc.identifier.issn | 0735-1097 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65443 | |
dc.format.extent | B177 - B178 | en_US |
dc.language.iso | en | en_US |
dc.rights | All rights reserved | |
dc.title | Optical Coherence Tomography assessment of the implantation of Everolimus-Eluting Bioresorbable Scaffolds against angiographic assessment: the clinical outcomes | en_US |
dc.type | Conference Proceeding | |
dc.rights.holder | Elsevier BV | |
dc.identifier.doi | 10.1016/j.jacc.2016.09.576 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397332900433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 18 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 68 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |